Bellevue Group Ag Argenx Se Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Argenx Se stock. As of the latest transaction made, Bellevue Group Ag holds 632,829 shares of ARGX stock, worth $395 Million. This represents 5.78% of its overall portfolio holdings.

Number of Shares

632,829

Previous 691,874 8.53%

Holding current value

$395 Million

Previous $298 Million 15.35%

% of portfolio

5.78%

Previous 4.98%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $25.6 Million - $32.6 Million	-59,045 Reduced 8.53%	632,829 $343 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $42.4 Million - $53.8 Million	-119,142 Reduced 14.69%	691,874 $298 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $20.8 Million - $24.1 Million	-58,192 Reduced 6.69%	811,016 $319 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $14.3 Million - $21.4 Million	-42,322 Reduced 4.64%	869,208 $331 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $4.34 Million - $6.45 Million	-11,754 Reduced 1.27%	911,530 $448 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $13.1 Million - $15.4 Million	36,356 Added 4.1%	923,284 $360 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $8.08 Million - $9.76 Million	-24,172 Reduced 2.65%	886,928 $330 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $2.82 Million - $3.32 Million	-8,246 Reduced 0.9%	911,100 $345 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $4.96 Million - $5.72 Million	-14,457 Reduced 1.55%	919,346 $332 Million
Q2 2022 Aug 11, 2022	SELL	$269.58 - $378.88 $5.24 Million - $7.36 Million	-19,435 Reduced 2.04%	933,803 $350 Million
Q1 2022 May 13, 2022	SELL	$254.45 - $351.06 $11.1 Million - $15.4 Million	-43,800 Reduced 4.39%	953,238 $301 Million
Q4 2021 Feb 10, 2022	BUY	$272.01 - $353.03 $3.56 Million - $4.62 Million	13,100 Added 1.33%	997,038 $349 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $2.92 Million - $3.47 Million	9,900 Added 1.02%	983,938 $297 Million
Q2 2021 Aug 12, 2021	BUY	$257.11 - $319.92 $5.01 Million - $6.23 Million	19,484 Added 2.04%	974,038 $293 Million
Q1 2021 May 12, 2021	BUY	$268.3 - $380.31 $2.47 Million - $3.5 Million	9,206 Added 0.97%	954,554 $263 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $3.39 Million - $4.21 Million	-13,668 Reduced 1.43%	945,348 $278 Million
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $1.08 Million - $1.36 Million	5,000 Added 0.52%	959,016 $252 Million
Q2 2020 Aug 13, 2020	SELL	$127.44 - $232.72 $2.61 Million - $4.77 Million	-20,488 Reduced 2.1%	954,016 $215 Million
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $709,027 - $1.08 Million	6,515 Added 0.67%	974,504 $128 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $559,597 - $862,102	-5,250 Reduced 0.54%	967,989 $156 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $3.24 Million - $4.3 Million	28,600 Added 3.03%	973,239 $110 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $106 Million - $131 Million	924,739 Added 4646.93%	944,639 $134 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $721,605 - $982,507	7,300 Added 57.94%	19,900 $2.48 Million
Q4 2018 Feb 12, 2019	BUY	$63.81 - $109.82 $804,006 - $1.38 Million	12,600 New	12,600 $1.21 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Argenx Se Transaction History